Monoclonal antibodies: magic bullets with a hefty price tag
AF Shaughnessy - Bmj, 2012 - bmj.com
Bmj, 2012•bmj.com
Sales of monoclonal antibodies are projected to reach more than $160 bn in the US alone
over the next few years so is it any wonder that drug companies fiercely protect their profits?
Allen Shaughnessy considers why these unique and complex drugs are so eyewateringly
expensive
over the next few years so is it any wonder that drug companies fiercely protect their profits?
Allen Shaughnessy considers why these unique and complex drugs are so eyewateringly
expensive
Sales of monoclonal antibodies are projected to reach more than $160bn in the US alone over the next few years so is it any wonder that drug companies fiercely protect their profits? Allen Shaughnessy considers why these unique and complex drugs are so eyewateringly expensive
bmj.com
